Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies
allinonemovie / Pixabay

Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies

  In a late July 2023 news release, global healthcare company Grifols shared that positive topline data was now available from a Phase 4 clinical study evaluating XEMBIFY (immune globulin…

Continue Reading Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies